Robert Lenz, MD, PhD
Robert Lenz, M.D., Ph.D. was appointed to the Board of Directors in August 2025. Dr. Robert Lenz served as the Executive Vice President and Head of Research and Development at Neumora Therapeutics, Inc. (Neumora) from September 2023 to March 2025. Prior to Neumora, he spent over a decade at Amgen Inc. in key leadership roles, including Senior Vice President, Head of Global Development. Earlier in his career, Dr. Lenz held positions of increasing responsibility at Abbott Laboratories, ultimately serving as Divisional Vice President for Neuroscience, Anesthesia, and Psychiatry Development. Throughout his career, Dr. Lenz has overseen the development of multiple medicines through regulatory approval. Dr. Lenz has served as a director and member of the Nominating and Corporate Governance Committee of LB Pharmaceuticals Inc. (Nasdaq: LBRX) since March 2026. Dr. Lenz earned his M.D. and Ph.D. from the University of Maryland School of Medicine and completed his neurology residency at the University of California, Los Angeles. He holds a Bachelor’s in Science in Chemistry and French from Dickinson College and has been recognized with multiple awards for innovation and leadership in the pharmaceutical industry.